Group structure
3 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1โ25 of 38
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BUPRENEX0.3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท Injectable | Buprenorphine | United States | Not marketed | 1981 |
| OPVEE2.7mg base/spray ยท Spray | Nalmefene | United States | Marketed | 2023 |
| PERSERIS KIT120mg | 90mg ยท For suspension, extended release | Risperidone | United States | Marketed | 2018 |
| SUBLOCADE100mg/0.5ml (100mg/0.5ml) | 300mg/1.5ml (200mg/ml) ยท Solution, extended release | Buprenorphine | United States | Marketed | 2017 |
| SUBLOCADE100 mg / 0.5 ml ยท Solution (Extended-Release) | Buprenorphine | Canada | Marketed | 2020 |
| SUBLOCADE300 mg / 1.5 ml ยท Solution (Extended-Release) | Buprenorphine | Canada | Marketed | 2020 |
| SUBOXONE2 mg + 0.5 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2007 |
| SUBOXONE8 mg + 2 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2007 |
| SUBOXONE16 mg + 4 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2018 |
| Suboxone | Buprenorphine, Naloxone | EU (EMA) | Authorised | 2006 |
| SUBOXONE12mg base; 3mg base | 2mg base; 0.5mg base | 4mg base; 1mg base | 8mg base; 2mg base ยท Film | Buprenorphine, Naloxone | United States | Marketed | 2010 |
| SUBOXONE2 mg + 0.5 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| SUBOXONE12 mg + 3 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| SUBOXONE12 mg + 3 mg ยท Tablet | Buprenorphine, Naloxone | Canada | Marketed | 2018 |
| SUBOXONE2MG BASE; 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 8MG BASE; 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท Tablet | Buprenorphine, Naloxone | United States | Not marketed | 2002 |
| SUBOXONE8 mg + 2 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| SUBOXONE4 mg + 1 mg ยท Film (Soluble) | Buprenorphine, Naloxone | Canada | Marketed | 2021 |
| Suboxone 12 mg/3 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine, Naloxone | Netherlands | Authorised | 2020 |
| SUBOXONE 12 MG/3 MG PELICULA SUBLINGUAL12,96 mg + 3,66 mg ยท Pelicula sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2020 |
| SUBOXONE 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES2 mg + 0,5 mg ยท Comprimido sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2014 |
| SUBOXONE 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES2 mg + 0,5 mg ยท Comprimido sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2006 |
| Suboxone 2 mg/0.5 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine, Naloxone | Netherlands | Authorised | 2020 |
| SUBOXONE 2 MG/0,5 MG PELICULA SUBLINGUAL2,16 mg + 0,61 mg ยท Pelicula sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2020 |
| Suboxone 4 mg/1 mg film voor sublinguaal gebruikFilm voor sublinguaal gebruik | Buprenorphine, Naloxone | Netherlands | Authorised | 2020 |
| SUBOXONE 4 MG/1 MG PELICULA SUBLINGUAL4,32 mg + 1,22 mg ยท Pelicula sublingual | Buprenorphine, Naloxone | Spain | Authorised | 2020 |